Integral BioSystems to Exhibit at 2018 AAPS PharmSci 360 Exhibition November 5-7 in Washington, DC

Boston area CRO Integral BioSystems will display in Booth 2447 at 2018 AAPS PharmSci 360 in the Walter E. Washington Convention Center November 5-7, 2018

Whether you want to formulate a new drug, or reformulate a known drug as a generic or 505(b)(2), Integral BioSystems can help”

— Dr. Shikha Barman

BEDFORD, MASSACHUSETTS, US, October 18, 2018 /EINPresswire.com/ — Bedford, MA – October 18, 2018 – Boston area CRO Integral BioSystems LLC, specializing in innovative pharmaceutical formulation development, will be in the spotlight as a participating exhibitor in Booth #2447 during the 2018 AAPS PharmSci 360 Annual Meeting and Exhibition to be held November 5th through 7th at the Walter E. Washington Convention Center in Washington, DC. With over 25 years of experience in all phases of cell and tissue targeted, sustained release pharmaceutical formulation development, the firm’s CEO and President, Dr. Shikha P. Barman, will be on hand to discuss the specific requirements of interested attendees. Dr. Barman will also give an oral presentation in location 152AB titled “Successes and Challenges in Establishing Q2/Q3 Similarity for Complex Generic Products” on Tuesday November 6th from 9:00 AM to 9:30 AM.

About the Event
AAPS PharmSci 360 combines the energy of a large scientific conference with the intimacy of a small niche gathering. With multiple tracks covering all aspects of the pharmaceutical sciences, hundreds of exhibitors, 7000 attendees from around the globe and unlimited networking opportunities to build on existing relationships and grow new ones, there will truly be something for everyone.

About Integral BioSystems
Integral BioSystems is a specialty drug delivery contract research organization that offers an integrated, practical approach to formulation development projects for both small molecule and large molecule drug candidates. Offering contract services to pharmaceutical companies to develop drug products through its CMC offerings in analytical method development, formulation development, process development, scale-up and technology transfer, the company also partners with pharmaceutical companies to co-develop products based on its proprietary pharmaceutical delivery systems.

The Company has developed numerous dosage forms for ophthalmic applications. Integral BioSystems has a translational approach to drug development, customizing delivery systems to achieve the biologically effective objectives of the therapy. Dosage forms are customized to achieve sustained release or targeted, tissue-focused delivery or fast-release/instant delivery, depending upon the desired product attributes.

For those seeking to develop a formulation for a new drug substance, a 505b2 product or a generic drug product, Dr. Barman will be available to answer questions about possible strategies for your particular application.

Dave Karasic
Integral BioSystems, LLC
617-820-8483
email us here


Source: EIN Presswire

U-Are Technologies: How AI and AR Will Revolutionize Education

LONDON, UNITED KINGDOM, October 17, 2018 /EINPresswire.com/ — The Education establishment needs a change, and we are about to embark upon such a change. And here at U-Are Technologies, we firmly believe that AI and AR will revolutionise our learning habits, helping transform the classroom learning experience.

Recently, education has become a bit of a hot topic among educators and policy reformers across the globe. There has been some changes made to the education system over the last decade or so, but not significant enough to get noticed. We remain within a classroom centric paradigm with learning focused on keeping students in the classroom with the hope that they will eventually harbinger a better future and contribution to society as a whole.

Moreover, the current education system remains focused on the collective with individual growth neglected. Also, our classroom environment revolves around sharing information and knowledge, and not its practical implementation.
The current classroom environment doesn’t work for everyone. The challenges remain as teachers need to create a framework where everyone fits in and not the other way around where individual growth is not at all prioritised. The current education system fails miserably when it comes to individual growth, socialisation, and connecting with others. Students do stay in a classroom, but they hardly interact with each other during learning. This leads to no flow of ideas and makes learning a stagnant process.

So, how do we solve these problems?

Applied Technologies to the Rescue: Implementing AR and AI Solutions
The growth of technology has seen its roots grow into education. The two important technologies that we at U-Are Technologies think will impact education in future are AR and AI.

It is on all of us to utilise these technologies to make learning more personal and help individuals improve their critical thinking, problem-solving skills, and overall ability to work on different problems and fields.

Immersive Education

To facilitate the next generation to get a proper education, we need to utilise immersive education using AI and AR. Computers have already started providing the playing field for the learners, whereas AR is now focusing on making it more immersive than ever. With virtual reality headsets readily available in the market, it is now possible for learners to transform their learning experience. Smartphones are providing the necessary tools to enable it. They are cheap and can be paired with cheap and durable virtual reality headsets such as Google Cardboards.

When it comes to the true AR experience, technology like Microsoft Hololens completely transforms how we visualise and learn. With AR devices, we can transform our learning experience and enhance creativity with the use of visuals. The images and the surroundings look real and can open a new perspective to the learners. For example, you can change your open room into a solar system where you can interact with planets.

Using AR can unlock the possibility to learn abstract concepts much faster. Visuals always interact with our brain in a special way. Students in a classroom will feel fascinated when they see, feel, and interact with the topics that they are learning. There are already AR education apps available in the market. Some of the notable ones are MyLab, a chemistry-related AR app, and Universe Sandbox, which let you explore the universe.

Machines and Learning

Artificial intelligence is transforming our world as we speak. It is already into sports, finance, self-driving cars, and so on. Its impact on education is yet to be seen. So, will it be able to transform education? The question can be answered by looking at the student-teacher relationship. AI is now capable of learning about us. Text-to-speech and voice recognition advancements also enable machines to interact with us. Examples include Cortana, Siri, Amazon Echo, and so on.

With all the necessary tools, only time will tell when AI will be able to replace or at least help teachers understand students and their requirements. It can become the perfect teacher that revolves around the learner's needs.
The capabilities of artificial intelligence are endless, and we have just started to explore its possibilities. Self-driving cars, for example, are a prime example of how artificial intelligence can be used to improve the world around us. With AI, we will be more connected, will be more inclined towards learning meaningful things, and will be able to customise our path accordingly.

Final Thoughts

Our education system is changing and we are arguably on the brink of a revolution in this field. Effectively applying emerging technologies can not only help us understand our learning habits but also transform the classroom learning experience using AI and AR.

If you are interested in learning more about how to apply these technologies to your training and education needs, then please do not hesitate to contact us at U-Are Technologies. We understand that one size does not fit all and can find a solution that meets every budget.

P. Jacobs
U-Are Technologies Limited
2039557558
email us here


Source: EIN Presswire

Is Hair Cloning the future of Hair Restoration?

FUE hair transplant still stands as the best method for hair restoration while we wait for hair cloning to become a reality.”

— Dr. Robert Jones, BSC, MD, ABHRS

TORONTO, ONTARIO, CANADA, October 17, 2018 /EINPresswire.com/ — Dr. Robert Jones, BSC, MD, ABHRS, and his team are always looking into innovations for hair restoration, and cloning might be the next evolution in non-invasive procedures. Currently, an international team of hair restoration doctors is perfecting this new procedure in the UK and looking to bring it to North America.

Hair cloning uses approximately 50 healthy follicle cells or dermal papillae that are extracted using the FUE procedure from the subject's areas that are not bald. They are then Cryopreserved which is a process where biological constructs are preserved by cooling to shallow temperatures (typically -80 °C or -196 °C using). They would then be shipped to a facility where they can be multiplied (cloned) and grown in a culture. These newly produced cells can be re-implanted in the areas of hair loss where they would act healthy and produce hair.

Current laws prevent any cloning in Canada and the United at the moment, but doctors are working diligently to make hair cloning a reality in North America. 85% of men by the age of 50 years old will have significant hair loss according to the American hair loss association. And by the time Women turn 40 years old, 40% of them will experience hair loss, according to the American Academy of Dermatology.

"FUE hair transplant still stands as the best method for hair restoration while we wait for hair cloning to become a reality." Says Dr. Jones. It uses a cutting-edge technique where the surgeon carefully removes the donor's hairs and then the surgeon will then implant them into the treatment area(s) for an immediate result. There are also other options for hair restoration options such as PRP (Platelet Rich Plasma) injections that use your blood platelets to stimulate growth, Minoxidil, a topical solution, Finasteride an oral regrowth medication and laser.

-30-

Dr. Robert Jones is recognized worldwide as an innovator in hair transplant techniques, leading the way with the latest technologies to hit the market since 2003. He was the first doctor in the world to perform large session FUE transplants. He now offers eyebrow and beard transplants and uses body hair transplants for those with limited donor sites and is the first to offer Celebrity non-shave FUE in Canada.
www.drrobertjones.com

To request an interview please contact publicist: Chris Binet, Publicist | Blend PR | o.416-907-0977 ext.4 | c. 416-567-4800 | chris@blendpr.com www.blendpr.com

Chris Binet
Blend PR
1-416-907-0977
email us here

Dr. Robert Jones


Source: EIN Presswire

Imbue Botanicals, LLC has signed a Co-Marketing agreement with Endocanna Health, Inc.

Imbue Botanicals

Endocanna Health DNA Test Kit

Imbue Botanicals to Co-Market CBD Products with DNA Tester Endocanna Health

PALM SPRINGS, CA, UNITED STATES, October 16, 2018 /EINPresswire.com/ — FOR IMMEDIATE RELEASE…Palm Springs, CA, October 11, 2018 – (Press Release Point) – Imbue Botanicals LLC, a Wyoming based company, has finalized an agreement with California-based Endocanna Health to co-market direct-to-consumer CBD products—and to co-market to one of Imbue’s major domains—the independent pharmacy arena.

Imbue Botanicals offers an extensive line of premium CBD products produced from organically grown Colorado hemp, including CBD tinctures, lotions, salves and capsules, for both people and pets.

Endocanna Health is the maker of the "Cannabinoid DNA Variant Test™"—the most comprehensive personalized cannabis DNA test on the market today. Developed by a team of specialists and scientists at Endocanna Heath, a biotechnology research company, this direct-to-consumer DNA test kit analyzes an individual's DNA markers and provides them with science-backed consumer recommendations based on their specific DNA.
“We're excited about introducing Imbue Botanicals to our customers, and look forward to working with Imbue’s independent pharmacy and retail clientele to help them make more informed buying decisions,” said Len May, Endocanna Health co-founder and CEO. “This co-marketing agreement will benefit both companies and will provide many alternative health solutions for our customers. We wanted a CBD product line to partner with that was U.S. grown and manufactured, a partner with innovative designs and branding, and above all, a partner with an efficacy that matches our corporate philosophy. We found that in Imbue Botanicals.”

“We’re thrilled to be aligned with such a forward-thinking company like Endocanna Health,” said Tom Bauer, Managing Partner for Imbue Botanicals. “Having this kind of arrangement for two companies that are so committed to patient care is truly a win-win.”

The co-marketing agreement begins this month.

ABOUT Imbue Botanicals, LLC:
Imbue Botanicals offers an extensive line of full spectrum, premium CBD products produced from organically grown Colorado hemp, including tinctures, capsules, topical CBD lotions and salves. Their premium Colorado grown hemp CBD products are non GMO, cruelty free, vegan and contain no added flavorings or sugars. Available through select retailers, their products offer exceptional quality, superb packaging and unmatched value.

Imbue Botanicals offers CBD products for both people and pets. For more information, visit: www.imbuebotanicals.com
Facebook: www.facebook.com/imbuebotanical
Instagram: www.instagram.com/imbuebotanicals_cbd

ABOUT Endocanna Health, Inc.:
Endocanna Heath is a biotechnology research company that utilizes a patent-pending algorithm and process for its Cannabinoid DNA Variant Report™. DNA for the test is obtained through either a simple saliva swab or existing genetic data from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. For a full spectrum experience, consumers can use their personalized reports to discover the right products for their specific genetics with product suggestions from Endocanna Health. For more information, visit:
www.endocannahealth.com
Instagram: @endocanna_health
Facebook: Endocanna Health

Paul Caudell
Joseph Allen Agencies, LLC
760-318-5401
email us here


Source: EIN Presswire

Intermountain Precision Genomics Launches NGS ONE Genomics Services

SALT LAKE CITY, UTAH, USA, October 16, 2018 /EINPresswire.com/ — Intermountain Precision Genomics has launched NGS ONE™ Genomics Services to empower researchers with uniquely intuitive and cost-effective services for their next generation sequencing studies in precision medicine, translational science and clinical research. This new service allows customers to request kits, obtain quotes and place orders online, with data made available via a secure cloud-based portal.

Helaman Escobar, Director of Intermountain’s Translational Science Center said, “We are thrilled to offer access to the technology and expertise of our high-throughput genomics center to a broader audience of clinicians and researchers.” Escobar adds “We specifically designed the NGS ONE™ service to be simple and intuitive to deliver solutions at scale for studies in precision medicine, research and other fields of science. The service is offered at an attractive price while providing a unique, collaborative environment for outside investigators to work directly with our scientists.”

NGS ONE™ supports projects where whole genome, human whole exome and RNASeq experiments are required. With options available that provide the best combination of pricing, data yields and high sample throughput, NGS ONE™ is designed to accommodate projects of different types and sizes. It aligns with Intermountain Healthcare’s commitment to helping people live the healthiest lives possible by advancing molecular knowledge in health and disease.

Intermountain Precision Genomics and NGS ONE™ are services provided by Intermountain Healthcare. Working at the forefront of medical science and technology, Intermountain Precision Genomics leverages the power of next-generation sequencing and state-of-the art genomic technology to enable translational research. Intermountain Healthcare is widely recognized as leader in clinical improvement and transforming healthcare through high quality and sustainable costs. For more information about NGS ONE™, visit: www.ngsone.org or ngsone@imail.org, or call (833) 4-NGSONE.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Treasure hunting exploration company, Global Marine Exploration Inc. brings action against State of Florida DOS.

Bobby Pritchett CEO of Global Marine Exploration "You cannot trust the State of Florida, or at least the people whom run it, very dishonest and misleading.IMO

CAPE CANAVERAL, FLORIDA, BREVARD, October 16, 2018 /EINPresswire.com/ — THE CIRCUIT COURT OF THE EIGHTEENTH JUDICIAL CIRCUIT
IN AND FOR BREVARD COUNTY, FLORIDA
Over a period of time, the Division issued GME six exploration permits with dig addenda for different three-square areas off the coast of Cape Canaveral. These turned up shipwreck evidence (anchors) but mostly resulted in identification of rocket debris.
12. The Florida Department of Environmental Protection, Division of State Lands, provided salvage easements for GME to use State-owned submerged lands for the areas and time periods for which the Division agreed for GME to explore for and recover shipwreck sites.

13. The Florida Department of Environmental Protection and the Federal Corps of Engineers contemporaneously issued construction permits to GME for it to use the designated submerged lands and navigable waters above for exploration and salvage.
14. On August 14, 2015, upon detailed application by GME, the Division issued a seventh Exploration Permit (# 2015-03) for GME to explore another three-square mile area of State waters in the Cape Canaveral vicinity to locate and report information about shipwreck sites in that designated area.
15. In proceeding with respect to Permit # 2015-03, as amended, GME discovered at least five separate locations of apparently distinct shipwreck sites which GME reported to the State as agreed. The locations of the discovered shipwreck sites and the methods used to identify those locations were proprietary, confidential trade secret information, and there is no requirement or agreement for public disclosure of such information.
16. GME provided site locations to the Division only after the Division repeatedly assured GME that this proprietary information would be maintained confidential and not disclosed to third-parties or used without GME’s consent.
17. On August 19, 2015, the Division issued Amendment One of Exploration Permit # 2015-03, recognizing GME’s successful completion of sensing survey within the designated area, allowing activity to identify newly uncovered cultural materials and limited test excavation and diagnostic artifact recovery for shipwreck identification purposes, and specifying that recovered artifacts would be included in the pool of artifacts considered for transfer to GME if a recovery permit is issued in the future for the same area. This Amendment explicitly authorized recovery of shipwreck artifacts, and promised to pool their value with the value of all ultimately recovered objects to calculate 80% thereof to be paid to GME.
18. On September 9, 2015, the Florida Department of Environmental Protection issued Notice of Modification of its construction permit to include areas approved by Exploration Permit # 2015-03, reciting that the modification includes amendment of the easement for treasure salvage investigations to include the new approved area.
19. On December 7, 2015, the State executed a Modified Sovereignty Submerged Lands Cultural Resource Recovery Easement for Salvage Exploration and Operation Purposes, stating that it was “for salvage operations only,” that “any artifacts or materials recovered by the applicant shall be disposed of pursuant to the contract issued by the Department of State;” and that the easement was “valid only after the Department of State has issued a contract for exploration or salvage and shall remain valid only so long as the Department of State’s contract is in full force and effect.”
20. Copies of the Division’s Exploration Permit # 2015-03, Amendment One, the Florida Department of Environmental Protection Salvage Work Permit Modification, and the State’s “Modified Sovereignty Submerged Lands Cultural Resource Recovery Easement for Salvage Exploration and Operation Purposes” for the approved area are attached as Exhibits A-1, A-2, A-3, and A-4, respectively.
21. GME recovered certain items and provided recorded identification of certain cannons and monuments to the Division by photograph and video.
22. GME made proper application for a recovery permit to authorize full recovery of artifacts from the discovered shipwreck sites.
23. The Division had never raised an issue nor made any negative response as to any work not having been done, or done improperly, in connection with any GME permit requirement.
24. GME became concerned when it learned that the Division considered that identified artifacts from one of the sites were from an old French naval ship and was negotiating the shipwreck finds with France for it to claim without GME’s involvement or consent.
25. GME filed a federal court complaint in admiralty in rem against “The Unidentified, Wrecked and (for Finders-Right Purposes) Abandoned Sailing Vessel,” seeking to establish its ownership under the Law of Finds.
26. Incident to its filing of this action, GME was required to deposit recovered artifacts under the federal court’s control.
27. The Division demanded that GME turn over those recovered artifacts, but GME could not comply because the federal court controlled the property.
28. The Division then suspended GME’s exploration permit and would not issue a recovery permit to GME, stating that the only cure was for possession of the artifacts recovered for identification purposes to be delivered to the Division.
29. The federal court transferred control of the identified artifacts to the Division, fulfilling this demand; however, the Division still refused or otherwise failed to reinstate GME’s exploration permit so it could identify artifacts at the other discovered sites, and refused to issue a recovery permit for it to complete recovery of the finds.
30. The Division’s actions caused GME significant loss and deprived GME from realizing compensation value from shipwreck sites and artifacts it discovered, contrary to GME’s investment-backed expectations in undertaking salvage operations

Robert Pritchett
Global MArine Exploration Inc
772-205-8184
email us here


Source: EIN Presswire

Global Cryonics Technology Market Research and Forecast 2018-2023

Global Cryogenic Technology Market

Orion Market Research

Global Cryonics Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Increasing demand for living cell preservation augmenting the growth”

— OMR Analyst

INDORE, INDIA, October 16, 2018 /EINPresswire.com/ — According to OMR analysis, the global cryonics technology market is expected to grow at a moderate CAGR during the forecast period 2018-2023. The cognitive computer market is estimated to grow modestly during the forecast period due to growing applications of the technology in healthcare industry to meet the medical necessity for creating the cryonic temperature to preserve the organs and chemicals. The global cryonics technology market can be bifurcated into by cryoprotective agents, which is further segmented into permeating cryoprotectants and non-permeating cryoprotectants; by method, it is segmented into slow freezing, vitrification and rapid freezing; by application, the market is further bifurcated into animal husbandry, fishery science, medical science, preservation of microbiology culture, and conserving plant biodiversity; by end-user, market is further classified into life science and healthcare facilities, and research laboratories; and by geography, it is further segmented into North America, Europe, Asia-Pacific and Rest of the World. The report provides detailed and insightful chapters which includes market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Full report of global cryonics technology market is available at https://www.omrglobal.com/industry-reports/cryopreservation-system-market/

Cryonics is living cells preservation technology that operates by creating extreme low temperature. Its applications are not only limited to human living cells but animal cells also. One of the growing factor for the cryonics technology market is increasing demand for organ transplantation due to increased organ surgeries. Major challenge for the market players is the dearth of skilled or qualified cryonic practitioners and government agenda framing stringent regulations for the practice of cryonics technology.

North America is leading the cryonics & cryogenic technology market with increased adoption of technology for animal husbandry and human living cells. Europe is the second largest region in the market share due to medical advancements in the region of Europe for organ preservation. With rising organ donation trend in the region of Asia-Pacific. Asia-Pacific is the fastest growing region due to adoption of technology because of stop aging process.

The report covers
Comprehensive research methodology of Global Cryonics
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Cryonics Market.
Insights about market determinants which are stimulating the Global Cryonics
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit https://www.omrglobal.com/reports-category/advanced-technologies/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:
LinkedIn

Global Cryogenic Technology Market Research By OMR


Source: EIN Presswire

Global Cognitive Computer Market Research and Forecast 2018-2023

Global Cognitive Computing Market

Orion Market Research

Global Cognitive Computing Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Cognitive computer market to mark substantial growth due to growing number of end-user industries, and economic & efficient technology demand”

— OMR Analyst

INDORE, INDIA, October 16, 2018 /EINPresswire.com/ — According to OMR analysis, the global cognitive computer market is expected to grow at a moderate CAGR during the forecast period 2018-2023. The cognitive computer market is estimated to grow modestly during the forecast period due to increasing adoption of the technology in end-user industries to facilitate the integration of human and computer with software services. The global cognitive computer market can be bifurcated into by technology, which is further segmented into natural language processing, machine learning, automated reasoning and others (information retrieval); by deployment, it is segmented into cloud and on premises by vertical, the market is further bifurcated into aerospace & defense, BFSI (Banking, Financial Services and Insurance), telecom & IT, consumer goods & retail, energy & power, tourism & travel, media & entertainment, education & research and others; and by geography, it is further segmented into North America, Europe, Asia-Pacific and Rest of the World. The report provides detailed and insightful chapters which includes market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Full report of global cognitive computer market is available at: https://www.omrglobal.com/industry-reports/cognitive-computing-market/

Cognitive computing is the technology platform which is based on artificial intelligence, machine learning and signal processing. The technology enables the human-computer interaction in more efficient manner due to integration of AI and machine learning with it. Use cases of the technology are face detection, speech recognition, sentimental analysis, fraud detection and risk management. Some of the major IT development in the field of cognitive computing made by software giants to solve real life problems are Vantage Software, CaféWell Concierge, Sofie, BrightMinded, WayBlazer, and Edge Up Sports. Technological advancements of the artificial intelligence, one of the key aspects of cognitive computing, led to rise in the investment of $5.1 billion in the year of 2016. Major breakthrough of cognitive computing is in the sector of healthcare where it facilitates to reduce cost by automating task such as de-identifying patient care records, and reviewing prior authorization requests. Along with its numerous benefits, cognitive computing face challenge of training process to tune the software system to work efficiently.

By geography North America is estimated to be the dominating region in the global cognitive computer market due to presence of established market players and growth in the artificial intelligence. North America is followed by Europe and Asia-Pacific. Asia-Pacific is the fastest growing region due to growth in Information Technology industry in the developing countries such as India and China.

The report covers
Comprehensive research methodology of global Cognitive Computing Market.
This report also includes detailed and extensive market overview with analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Cognitive Computing Market.
Insights about market determinants which are stimulating the global Cognitive Computing Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/advanced-technologies/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:
LinkedIn

Global Cognitive Computer Market Research By OMR


Source: EIN Presswire

Global Genome Editing Market Research and Forecast 2018-2023

Global Genome Editing Market

Orion Market Research

Genome editing market, size, share, market intelligence, company profiles, market trends, strategy, research report, analysis, forecast 2018-2023

Increasing funding for genome editing research is primarily driving the global genome editing market”

— OMR Analyst

INDORE, INDIA, October 16, 2018 /EINPresswire.com/ — According to OMR analysis, the global genome editing market is expected to grow significantly during the forecast period (2018-2023) coupled with increasing funding for genome editing research. Additionally, the global genome editing market is segmented on the basis of technologies, application, end-users and regional outlook. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, patent analysis, analyst insights and predictive analysis of the market.

Full report of global genome editing market is available at: https://www.omrglobal.com/industry-reports/genome-editing-market/

Increasing funding for genome editing research is primarily contributing towards the market growth. National Institute of Health (NIH) has declared a plan in Jan 2018 to fund $190 million for research in genome editing. It is an effort intended for removing restrictions that reduces the use of genome editing for the treatment of patients. This new program named Somatic Cell Genome Editing by NIH will grant funding to the biomedical researchers in the six years from the beginning of 2018. These biomedical researchers will work together to improve the delivery mechanisms that enables to target gene editing tools among patients and develop new and advanced genome editors. In addition, they will develop assays to test the safety and effectiveness of the genome editing tools in human and animal cells as well as assemble a genome editing toolkit that will contain subsequent tools, methods and knowledge to be shared with the scientific community.
Moreover, in June 2018, Precision Biosciences, Inc. (a US-based biotechnology firm) closed an oversubscribed series B funding of $110 million. This funding is aimed for efforts on product development which is based on its platform, ARCUS genome editing. The funding was led by ArrowMark Partners and other new investors such as Franklin Templeton Investments, Cowen Healthcare Investments and Adage Capital Management. This is intended to broaden the applications of its genome editing platform, ARCUS in the areas of genetic disease and immuno-oncology, which in turn is expected to lead the way for the company to set up as a wholly integrated biotechnology firm. they will use this funding to leverage and expanding its product portfolio. Such kinds of funding activities are showing increasing focus on genome editing techniques, which in turn will lead to propel the market growth.

The report covers
Comprehensive research methodology of global Genome editing market.
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global genome editing market.
Insights about market determinants which are stimulating the global genome editing market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/biotechnology/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:
LinkedIn

Global Genome Editing Market Research By OMR


Source: EIN Presswire

Dr. Elissa J. Santoro to be Featured on CUTV News Radio

LIVINGSTON, NEW JERSEY, UNITED STATES, October 16, 2018 /EINPresswire.com/ — When caught early, about 90 percent of women diagnosed with breast cancer will live a full life. If caught at Stage 0, then almost 100% are cured. 50 years ago, however, four out of five patients were dead within five years. There were no mammograms at that time for early detection and almost no attention had been paid to supporting patients emotionally as well as physically throughout treatment.

But that all changed slowly but surely thanks to the efforts of pioneering physicians like Dr. Elissa Santoro. A surgical oncologist since 1970, today Dr. Elissa Santoro serves as Breast Care Consultant for RWJS Barnabas Health Center. Now 80 years old, and no longer performing surgery, Dr. Santoro care for even more patients than ever while teaching the next generation of surgical oncologists all she has learned as a practicing physician.

“Medicine is really a healing art as well as a science,” says Dr. Santoro. “I had always wanted to be a healer and not just a technician because no doctor has yet cured mortality, so while we're here, our focus should be on quality of life.”

Dr. Santoro has been on the front lines as the field of cancer treatment has evolved. In fact, she has been responsible for much of that evolution, and the approach to care those who have been diagnosed can receive today. When integrative medicine was still in its infancy, Dr. Santoro pioneered a holistic integrative breast care for women, immersing patients into compete healing of mind, body and spirit.

“As the only woman surgical oncologist in New Jersey, I found there was a terrible need for a more holistic approach,” says Dr. Santoro. “I had the ability to open up a practice for breast care and treatment center where the patient could be diagnosed, operated on if needed, chemotherapy if needed, as well as treating the mind, body, and spirit. That’s what was missing. In that era being told you had breast cancer, meant you would die in five years and suffer through mutilating surgeries like radical mastectomies. I would refer them for counseling, for healing. If they had a religion, I'd get the support of their pastors or rabbis.”

And as the field has evolved, women have shown they want women to be their doctor.

“The breast is very symbolic,” says Dr. Santoro, “so it's a great field for a woman because we can better understand the psychosexual component of this diagnosis. It affects marriages, relationships.

“We've come a long, long way and there's so much on the horizon,” says Dr. Santoro. “We're learning more and more about the immune cells and identifying the patients at risk using gene testing. Maybe one day surgery will have only minor role, but it's been a big change from 1970 to 2018.”

CUTV News Radio will feature Dr. Elissa J. Santoro, MD., FACS in an interview Jim Masters on October 18th at 12pm EDT.

Listen to the show on BlogTalkRadio. If you have a question for our guest, call (347) 996-3389.

For more information on Dr. Elissa J. Santoro, MD., FACS, visit www.elissa-santoro1.info

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire